# Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis

> **NCT07380347** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Neonatal Sepsis

## Interventions

- **DRUG:** N-Acetyl Cysteine (NAC)
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT07380347
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380347, "Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07380347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*